Collectively, these results indicate that overexpression of MB21D2 suppresses the proliferation, migration, and invasion of ESCC cells, thereby potentially serving as a mechanism of action against ESCC in vitro. This evidence concerns the gene MB21D2 and esophageal squamous cell carcinoma.